MODAFINIL NORGE - AN OVERVIEW

Avoid concomitant usage of tucatinib with CYP3A substrates, where by minimal concentration modifications might bring about serious or life-threatening toxicities. If unavoidable, cut down CYP3A substrate dose according to products labeling.modafinil will lower the level or impact of fruquintinib by affecting hepatic/intestinal enzyme CYP3A4 metabol